Table 4

Univariate analysis related to distant metastases-free survival in propensity score-matched 226 early stage breast cancers

Patients, (n)Recurrence7-year DFS %*HR for Recurrence95% CI HRp Value
Age (≤35/>35 years)9/2170/28100/840.00000.03 to 3.850.3961
Pre/post menopausal121/10521/777/920.320.16 to 0.730.0058
Histological type0.5773
 Ductal20523585
 Lobular15577
 Others60100
Tumour size0.480.21 to 1.000.0512
 T11451389
 T2811576
Nodal status0.320.13 to 0.640.0023
 N01481192
 N1781770
Grading0.1151
 Low282100
 Intermediate1301586
 High681172
Oestrogen receptor1.440.54 to 4.170.4240
 Positive1872286
 Negative39674
Progesterone receptor1.400.59 to 3.540.4121
 Positive1772086
 Negative49878
HER2 status0.610.24 to 1.370.2151
 Negative1741887
 Positive521076
Triple negativity1.010.30 to 3.410.9750
 Yes22378
 No2042585
Ki-671.010.47 to 2.140.9798
 ≤20731388
 >201531582
NLR0.400.20 to 0.890.0235
 Low (≤1.97)113888
 High (> 1.97)1132081
  • p Values highlighted in bold are statistically significant.

  • *Median follow-up time.

  • NLR, neutrophil to lymphocyte ratio.